Business Description
InventisBio Co Ltd
ISIN : CNE100005Q22
Share Class Description:
SHSE:688382: Class ACompare
Compare
Traded in other countries / regions
688382.China IPO Date
2022-07-25Description
InventisBio Co Ltd is an innovative drug research and development enterprise based in China with a global perspective, focusing on major diseases such as tumors and metabolic diseases. It has independently developed a series of innovative targeted drugs with patent protection, covering non-small cell lung cancer, breast cancer, colorectal cancer and other solid tumors, as well as hyperuricemia and metabolic diseases such as gout.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 176.59 | |||||
Equity-to-Asset | 0.93 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 15.6 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 39.3 | |||||
3-Year FCF Growth Rate | -7.1 | |||||
3-Year Book Growth Rate | 16.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 47.55 | |||||
9-Day RSI | 39 | |||||
14-Day RSI | 36.37 | |||||
6-1 Month Momentum % | -39.77 | |||||
12-1 Month Momentum % | -43.44 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 14.99 | |||||
Quick Ratio | 14.99 | |||||
Cash Ratio | 13.5 | |||||
Days Sales Outstanding | 242.4 | |||||
Days Payable | 6415.1 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.7 | |||||
Shareholder Yield % | 0.09 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.92 | |||||
Operating Margin % | -145.79 | |||||
Net Margin % | -128.41 | |||||
FCF Margin % | -165.34 | |||||
ROE % | -12.28 | |||||
ROA % | -11.49 | |||||
ROIC % | -260.37 | |||||
ROC (Joel Greenblatt) % | -424.97 | |||||
ROCE % | -12.34 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 21.34 | |||||
PB Ratio | 2.14 | |||||
Price-to-Tangible-Book | 2.14 | |||||
EV-to-EBIT | -8.19 | |||||
EV-to-EBITDA | -8.19 | |||||
EV-to-Revenue | 10.61 | |||||
EV-to-FCF | -6.42 | |||||
Price-to-Net-Current-Asset-Value | 2.18 | |||||
Price-to-Net-Cash | 2.44 | |||||
Earnings Yield (Greenblatt) % | -12.21 | |||||
FCF Yield % | -8.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
InventisBio Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 194.133 | ||
EPS (TTM) (Â¥) | -0.43 | ||
Beta | 0 | ||
Volatility % | 51.46 | ||
14-Day RSI | 36.37 | ||
14-Day ATR (Â¥) | 0.371235 | ||
20-Day SMA (Â¥) | 7.674 | ||
12-1 Month Momentum % | -43.44 | ||
52-Week Range (Â¥) | 6.62 - 18.41 | ||
Shares Outstanding (Mil) | 576.72 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InventisBio Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InventisBio Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
InventisBio Co Ltd Frequently Asked Questions
What is InventisBio Co Ltd(SHSE:688382)'s stock price today?
The current price of SHSE:688382 is ¥7.17. The 52 week high of SHSE:688382 is ¥18.41 and 52 week low is ¥6.62.
When is next earnings date of InventisBio Co Ltd(SHSE:688382)?
The next earnings date of InventisBio Co Ltd(SHSE:688382) is .
Does InventisBio Co Ltd(SHSE:688382) pay dividends? If so, how much?
InventisBio Co Ltd(SHSE:688382) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |